| 摘要 |
The invention relates to new therapeutic approaches for treating cancer, in particular hepatocellular carcinoma, with nanoparticles loaded with a chemotherapeutic antitumoral agent. In particular, it relates to the treatment of cancer by administration of said nanoparticles by intravenous infusion for at least 2 hours in order to prevent toxicological side effects and increase the benefit/risk ratio of the treatment. |
